Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MD Anderson Cancer Center Madrid is a specialized oncology hospital in Madrid, Spain and the European MD Anderson-branded center operated within the Hospiten group. The center focuses on cancer prevention, diagnosis, surgery, systemic therapy, radiotherapy, supportive care, and clinical research, including a dedicated Phase I clinical trials unit. It is not a drug-development biotech company with a proprietary therapeutic pipeline; rather, it is a commercial healthcare provider and oncology research hospital serving cancer patients. The hospital operates under the MD Anderson name in Spain and is positioned as a high-acuity cancer referral center with multidisciplinary oncology services and access to investigational therapies through clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MD Anderson Cancer Center Madrid.